Regenovue Plus (Lido) — NeoGenesis 100% Cross-linked HA Dermal Filler — 1.1ml
- NeoGenesis 100% cross-linking — 24 mg/mL HA
- 3 mg/mL lidocaine, >95% gel integrity at 12 months
- Ultra-low endotoxin <0.0015 IU/mg
- For licensed professionals only
| 1 – 2 boxes | $48.10 / box |
| 3 – 9 boxes | $45.70 / box |
| 10 – 19 boxes | $43.29 / box |
| 20 – 29 boxes | $41.85 / box |
| 30+ boxes | Contact for quote |
What Is Regenovue Plus (Lido) — NeoGenesis 100% Cross-linked HA Dermal Filler — 1.1ml?
**Regenovue Plus (Lido)** is a three-variant Korean HA dermal filler series manufactured by NeoGenesis Co., Ltd., utilizing patented 100% cross-linking technology with low-BDDE process, delivering 24 mg/mL cross-linked hyaluronic acid with 3 mg/mL lidocaine, >95% gel integrity at 12 months, and ultra-low endotoxin (<0.0015 IU/mg) for professional facial contouring and volumization.
Regenovue Plus features NeoGenesis' patented 100% cross-linking technology that delivers exceptional gel integrity — >95% retained at 12 months — ensuring durable, predictable results. With ultra-low endotoxin levels below 0.0015 IU/mg and low-BDDE processing, it offers outstanding purity and biocompatibility. Three variants (Fine Plus, Deep Plus, Sub-Q Plus) at a uniform 24 mg/mL HA concentration with 3 mg/mL lidocaine cover the full treatment spectrum from mid-dermal fine line correction to deep subcutaneous volumization, with high-viscosity gel (G' >250 Pa) enabling precise sculpting with 30% less swelling versus standard fillers.
Specifications
| Product name | Regenovue Plus (Lido) — 100% Cross-linked HA Filler |
|---|---|
| Active ingredient | Cross-linked HA 24 mg/mL + Lidocaine 3 mg/mL |
| Volume | 1 × 1.1ml pre-filled syringe |
| Cross-linking | 100% cross-linked (patented low-BDDE) |
| Gel integrity | >95% at 12 months |
| Endotoxin | <0.0015 IU/mg |
| Viscosity | 140,000 mPa·s |
| G' (Storage Modulus) | >250 Pa |
| HA Source | Bacterial fermentation, non-animal origin |
| Application | Mid-dermal to subcutaneous per variant |
| Treatment areas | Fine lines, periorbital, lips, NLF, marionettes, cheeks, chin, jawline, body contour |
| Origin | South Korea (NeoGenesis Co., Ltd.) |
| Certification | CE, ISO 13485 |
| Storage | 2–25°C, do not freeze, protect from direct sunlight |
| Shelf life | 24 months unopened |
Key Benefits
- Patented 100% cross-linking delivers >95% gel integrity at 12 months for durable, predictable results
- Ultra-low endotoxin (<0.0015 IU/mg) and low-BDDE processing ensure exceptional biocompatibility
- High-viscosity gel (G' >250 Pa) enables precise sculpting with 30% less swelling than standard fillers
- Three variants (Fine Plus/Deep Plus/Sub-Q Plus) cover every dermal depth from mid-dermis to subcutaneous
- Room-temperature stable storage (2–25°C) eliminates cold-chain logistics
Suggested Treatment Protocol
Treatment protocol varies by variant. Regenovue Fine Plus is injected into the mid dermis using a 30G needle for fine lines, lip border, and periorbital area. Regenovue Deep Plus targets the mid-to-deep dermis using 27G needles for nasolabial folds, marionette lines, and lip body. Regenovue Sub-Q Plus is placed in the subcutaneous plane using 25G or 27G needles for cheek augmentation, chin enhancement, jawline contouring, and body contouring. The exact injection depth, volume, and treatment schedule should be determined by the treating practitioner based on individual patient anatomy and aesthetic goals.
Superb quality. A staple in my practice.
Exceptional performance. Very satisfied with this product.
Outstanding quality. Highly recommend for professional use.
Good value for the price. Our clinic has been satisfied with the results so far.
The 1.1ml syringe format is convenient for our clinic workflow. Less waste compared to the 1.5ml syringes we used to buy.
Please log in to leave a review.